Canada · Delayed Price · Currency is CAD Nirvana Life Sciences Statistics
Total Valuation
CSE:NIRV has a market cap or net worth of CAD 684,699. The enterprise value is 782,759.
| Market Cap | 684,699 |
| Enterprise Value | 782,759 |
Important Dates
The next estimated earnings date is Tuesday, December 9, 2025.
| Earnings Date | Dec 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:NIRV has 22.82 million shares outstanding. The number of shares has increased by 93.19% in one year.
| Current Share Class | 22.82M |
| Shares Outstanding | 22.82M |
| Shares Change (YoY) | +93.19% |
| Shares Change (QoQ) | +373.19% |
| Owned by Insiders (%) | 5.60% |
| Owned by Institutions (%) | 1.57% |
| Float | 21.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -1.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.26 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,048.11% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 63.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.00% in the last 52 weeks. The beta is 0.22, so CSE:NIRV's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -96.00% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.17 |
| Relative Strength Index (RSI) | 4.73 |
| Average Volume (20 Days) | 227 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -336,032 |
| Pretax Income | -346,425 |
| Net Income | -346,296 |
| EBITDA | n/a |
| EBIT | -336,032 |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 1,744 in cash and 104,789 in debt, giving a net cash position of -103,045 or -0.00 per share.
| Cash & Cash Equivalents | 1,744 |
| Total Debt | 104,789 |
| Net Cash | -103,045 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -527,733 |
| Book Value Per Share | -0.02 |
| Working Capital | -527,732 |
Cash Flow
| Operating Cash Flow | -1.02M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:NIRV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -93.19% |
| Shareholder Yield | n/a |
| Earnings Yield | -50.58% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 24, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Mar 24, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |